Assessment of the Illumina MiSeq massively parallel sequencing platform for simultaneous analysis of Hepatitis C virus resistance to all direct-acting antivirals combination regimes
Por:
Martro, E, Saludes, V, Salvatierra, K, Rech, G, Sumoy, L, Artacho, A, Morillas, R, Berenguer, M and Lopez-Labrador, F
Publicada:
1 sep 2016
Resumen:
|